On the basis of multivariate analysis, the AFP level before the DAA therapy and number of curative treatments for HCC before the DAA therapy were identified as independent factors that were significantly associated with HCC recurrence after the DAA therapy. This evidence concerns the gene AFP and hepatocellular carcinoma.